Kingdom Financial Group LLC. Invests $914,000 in CME Group Inc. $CME

Posted by Stanley Muller on May 22nd, 2026

Kingdom Financial Group LLC. purchased a new position in shares of CME Group Inc. (NASDAQ:CME – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 3,348 shares of the financial services provider’s stock, valued at approximately $914,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Asset Dedication LLC raised its stake in shares of CME Group by 64.9% during the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after buying an additional 37 shares during the last quarter. FNY Investment Advisers LLC acquired a new position in shares of CME Group during the 4th quarter worth $27,000. Legacy Wealth Managment LLC ID raised its stake in shares of CME Group by 191.9% during the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock worth $29,000 after buying an additional 71 shares during the last quarter. Global Wealth Strategies & Associates raised its stake in shares of CME Group by 1,250.0% during the 4th quarter. Global Wealth Strategies & Associates now owns 108 shares of the financial services provider’s stock worth $30,000 after buying an additional 100 shares during the last quarter. Finally, Anfield Capital Management LLC raised its stake in CME Group by 197.4% in the 4th quarter. Anfield Capital Management LLC now owns 113 shares of the financial services provider’s stock valued at $31,000 after purchasing an additional 75 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Buying and Selling

In other CME Group news, General Counsel Jonathan L. Marcus sold 3,291 shares of the company’s stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total value of $1,097,120.67. Following the completion of the transaction, the general counsel owned 7,192 shares in the company, valued at $2,397,597.04. This represents a 31.39% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction that occurred on Friday, May 15th. The shares were sold at an average price of $298.51, for a total value of $10,447,850.00. Following the completion of the transaction, the chief executive officer directly owned 55,630 shares in the company, valued at approximately $16,606,111.30. The trade was a 38.62% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 48,244 shares of company stock worth $14,598,037 in the last 90 days. 0.30% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the stock. Morgan Stanley cut their target price on shares of CME Group from $362.00 to $353.00 and set an “overweight” rating for the company in a research note on Thursday, April 23rd. The Goldman Sachs Group cut their target price on shares of CME Group from $275.00 to $267.00 and set a “sell” rating for the company in a research note on Thursday, April 23rd. Wall Street Zen downgraded shares of CME Group from a “hold” rating to a “sell” rating in a research note on Sunday, April 26th. Weiss Ratings raised shares of CME Group from a “buy (b+)” rating to a “buy (a-)” rating in a research note on Monday, March 2nd. Finally, Raymond James Financial boosted their target price on shares of CME Group from $310.00 to $320.00 and gave the company an “outperform” rating in a research note on Monday, April 6th. Two research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $305.29.

Check Out Our Latest Report on CME Group

CME Group Stock Down 0.3%

NASDAQ CME opened at $289.29 on Friday. The stock has a market cap of $104.83 billion, a PE ratio of 24.68, a P/E/G ratio of 3.51 and a beta of 0.23. CME Group Inc. has a fifty-two week low of $257.17 and a fifty-two week high of $329.16. The business has a 50 day moving average price of $296.62 and a two-hundred day moving average price of $289.10. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME – Get Free Report) last released its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. The firm had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.CME Group’s quarterly revenue was up 14.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.80 EPS. As a group, sell-side analysts predict that CME Group Inc. will post 12.26 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th will be issued a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date is Tuesday, June 9th. CME Group’s dividend payout ratio is currently 44.37%.

CME Group Company Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.